Lucy Mupfumi

Resourceful Technical Advisor brings extensive understanding of TB, HIV and SRH and extensive experience providing technical support to low and middle income countries. Over 16-plus year experience designing and implementing effective public health strategies, championing the adoption and scale up of point of care technologies and contributing to workforce development. Demonstrates strong autonomy, effectively managing multiple tasks with a proactive and accountable approach to project deliverables.

• Project Management (UNOPS - in progress)
• Aspiring People Leaders (UNOPS - 2023)
• Introduction to Infectious Disease Modelling (LSHTM - 2021)
• Advanced TB Diagnostics (McGill - 2021)
• Good Clinical Practice (CITI - 2019)
• TB Research Methods (McGill - 2018)
• Genomic Epidemiology of Infectious Diseases (McGill - 2018)
• Good Clinical Laboratory Practice (DAIDS - 2014)
• Principles of STD/HIV research (University of Washington - 2014)
• Biostatistics, Epidemiology and Monitoring and Evaluation (Summer School-UC Berkeley, USA - 2011)

• African Society for Laboratory Medicine, Technical assistance for TB networks, 03/2024, 04/2024, Assessed the existing gaps within the national TB laboratory strategic plans of 21 countries in Africa against the WHO's End TB strategy and Laboratory Strengthening targets. Developed a manuscript currently under peer review highlighting the need for a strategic decision tool that can enable the development and review of national TB laboratory strategic plans aligned with the End TB Strategy and WHO recommendations.
• Umoyo Public Health Consultants, Subject Matter Expert - TB Diagnostics, 08/2021, 09/2021, Refined a framework that countries can adopt to develop national TB laboratory strategic plans aligned with the objectives of the End TB strategy and Laboratory Strengthening targets. This framework can serve as a valuable tool for countries to assess their existing plans, identify gaps, and align their strategies with global guidelines.
• African Society for Laboratory Medicine, e-Learning and M&E Technical Consultant, 03/2021, 03/2022, Managed e-learning curricula delivery for a project that aimed to enhance laboratory workforce development on antimicrobial resistance (AMR) surveillance in Africa. This included designing the format for e-learning courses, liaising with content developers, and evaluating learner metrics. Developed Excel dashboards for monitoring learner engagement, offering timely analysis and clear recommendations for ASLM's self-directed learning improvement. Ensured face-to-face training met expected standards through review of country team reports.

Authored and co-authored multiple peer-reviewed journal articles , establishing expertise in the field. Select publications are shown below:

• Youth and healthcare workers' perspectives on the feasibility and acceptability of self-testing for HIV, Hepatitis and Syphilis among young people: qualitative findings from a pilot study in Gaborone, Botswana, Plos One, Kyegombe N, Ajibola G, Sakoi-Mosetlhi M, Rebatenne T, Anderson M, Gaseitsiwe S, Makhema J, Ngwenya U, Moyo S, Sauzet O, Mupfumi, L., 2023
• Sub-Saharan Africa preparedness and response to the COVID-19 pandemic: A perspective of early career African scientists, Wellcome Open Research, Umviligihozo G, Mupfumi L, Sonela N, Naicker D, Obuku EA, Koofhethile K et al, 2020
• High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National ART programme between 2011 and 2015, AIDS, Mupfumi L, Moyo S, Shin SS, Wang Q, Zetola N, Molebatsi K et al, 2019
• Detection of second line Drug resistant Mycobacterium tuberculosis isolates in Botswana, Pathogens, Mogashoa T, Melamu P, Deredinger B, Ley SD, Streicher EM, Iketleng T, Mupfumi L, et al, 2019
• Brief report: High rates of adverse birth outcomes in HIV and Syphilis co-infected women in Botswana, JAIDS, Shava E, Moyo S, Zash R, Diseko M, Dintwa EN, Mupfumi L et al, 2019
• Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis, Lancet Glob Health, Tanna GL, Khak AR, Theron G, McCarthy K, Cox H, Mupfumi L et al, 2019
• Mycobacterium tuberculosis next-generation whole genome sequencing: Opportunities and Challenges, Tuberculosis Research and Treatment, Iketleng T., Lessells R., Dlamini MT., Mogashoa T., Mupfumi L., Moyo S. et al, 2018

• I served as a technical expert in diagnostic network assessments and TB program reviews, contributing to the alignment of national strategic plans with global goals and targets, ensuring the effective implementation of evidence-based strategies.
• Established and maintained effective working relationships with international and national staff at all levels through providing technical assistance and conducting site monitoring visits as well as organizing country-experience sharing webinars to disseminate the project experience and allow sharing of best practices between countries.
• Provided valuable input in discussions with the Ministry of Health regarding the potential for self-testing among high-risk individuals, and the implementation of dual HIV and syphilis testing.
• Promoted within one year of joining the organization to lead the clinical trials laboratory and shape laboratory strategy.
• As technical advisor on a treatment optimization project, informed decentralization plans for CD4 testing in remote clinics.
• Designed one of the first clinical trials evaluating the impact of Xpert MTB/RIF on patient outcomes in the context of HIV that contributed to the development of the first WHO guidelines on rapid molecular testing for TB.